We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tipifarnib in Subjects With Myelodysplastic Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02779777
Recruitment Status : Terminated (Lack of efficacy)
First Posted : May 20, 2016
Last Update Posted : February 5, 2020
Sponsor:
Information provided by (Responsible Party):
Kura Oncology, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2019
Actual Study Completion Date : January 24, 2020